Announcements Trials
Browse Landscape

Status

Recruiting 22Active not recruiting 14Completed 5Not yet recruiting 4Withdrawn 1Terminated 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-resistant Prostate Cancer 1

Interventions

tucatinib 1talquetamab 1niraparib 1futibatinib 1erdafitinib 1cemiplimab 1amivantamab 1adagrasib 1Trastuzumab 1TIC10 compound 1Prednisone 1Prednisolone 1Capecitabine 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Approved for marketing × Prednisolone × 1 year × Clear all
NCT05401214 2025-06-13

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Janssen Research & Development, LLC

Approved for marketing
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡